Darifenacin HBr
CAS: 133099-07-7
Ref. 3D-FD10806
1g | 200.00 € | ||
2g | 315.00 € | ||
5g | 478.00 € | ||
10g | 598.00 € | ||
500mg | 135.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Product Information
Name:
Darifenacin HBr
Controlled Product
Synonyms:
- (1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide
- (S)-3-(Carbamoyldiphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine hydrobromide
- 2-[(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide
- 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide (1:1)
- 2-{1-[2-(2,3-Dihydro-1-Benzofuran-5-Yl)Ethyl]Pyrrolidin-3-Yl}-2,2-Diphenylacetamide Hydrobromide (1:1)
- 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, hydrobromide (1:1), (3S)-
- 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, monohydrobromide, (3S)-
- 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, monohydrobromide, (S)-
- Darilong
- Emselex
- See more synonyms
- Enablex
- UK 88525-04 hydrobromide
- Uk 88525-04
- {1-[2-(2,3-Dihydrobenzofuran-5-Yl)Ethyl]-3-Pyrrolidnyl}-2,2-Diphenylacetamide Hydrobromide
Description:
Muscarinic (M3) ACh receptor antagonist
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
507.46 g/mol
Formula:
C28H30N2O2·HBr
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-FD10806 Darifenacin HBr
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.